Valuation: FDC Limited

Market Cap 61.32B 644M 578M 534M 484M 904M 915M 6.39B 2.54B 32.09B 2.42B 2.37B 102B P/E 2025
24.1x
P/E 2026 18.6x
Enterprise Value 56.26B 591M 530M 490M 444M 829M 839M 5.86B 2.33B 29.44B 2.22B 2.17B 93.46B EV / Sales 2025
2.8x
EV / Sales 2026 2.18x
Free-Float
30.06%
Yield 2025
1.27%
Yield 2026 1.56%
1 day+1.25%
1 week+12.10%
Current month+12.24%
1 month+8.93%
3 months-7.95%
6 months+4.84%
Current year-9.91%
1 week 330.5
Extreme 330.5
385
1 month 321.5
Extreme 321.5
385
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
473.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 2009-11-18
Chief Executive Officer 63 1993-09-29
Director of Finance/CFO - 2025-10-23
Director TitleAgeSince
Director/Board Member 48 2001-12-31
Director/Board Member 63 1993-09-29
Chairman 90 2026-03-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%+12.10%-13.44%+4.52% 644M
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+0.34%+1.84%+30.70%+54.27% 294B
-0.45%+1.19%+2.89%+26.08% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.26%+2.34%+35.23%+69.22% 403.78B
Weighted average by Cap. +0.26%+1.51%+44.51%+89.09%

Financials

2025 2026
Net sales 21.08B 221M 199M 184M 166M 311M 314M 2.2B 874M 11.03B 831M 813M 35.02B 21.71B 228M 205M 189M 171M 320M 324M 2.26B 900M 11.36B 855M 837M 36.06B
Net income 2.67B 28.01M 25.13M 23.24M 21.04M 39.32M 39.79M 278M 111M 1.4B 105M 103M 4.43B 2.81B 29.55M 26.51M 24.51M 22.2M 41.47M 41.97M 293M 117M 1.47B 111M 109M 4.68B
Net Debt -5.15B -54.07M -48.51M -44.85M -40.62M -75.89M -76.8M -536M -214M -2.69B -203M -199M -8.55B -5.06B -53.13M -47.67M -44.07M -39.92M -74.57M -75.48M -527M -210M -2.65B -199M -195M -8.41B
Projected Income Statement - Annual - FDC Limited
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
7,076
Date Price Change Volume
26-10-29 ₹381.40 +1.26% 43,611
26-10-28 ₹376.65 +6.41% 67,947
26-10-27 ₹353.95 +2.36% 118,092
26-10-26 ₹345.80 +2.05% 12,514
26-10-23 ₹338.85 -0.40% 5,406
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B